Search research articles
Contact Us
Filters
Showing results (151-160 of 254) with videos related to
Page
of 26
Sort By:
Clinical and Vaccine Immunology : CVI
|
August 17, 2012
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure
Julio Hawkins, Srinivas Kodali, Yury V Matsuka, et al.
The Lancet. Infectious Diseases
|
August 14, 2023
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial
James Peterson, Daniel Drazan, Hanna Czajka, et al.
Open Forum Infectious Diseases
|
December 8, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children
Isabel Vogler, Stephanie Renken, Rolf Hilker, et al.
The Journal of Infection
|
October 5, 2019
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine
Helen S Marshall, James Baber, Peter Richmond, et al.
Protein Expression and Purification
|
December 22, 1999
Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae
J C Cook, J G Joyce, H A George, et al.
European Cells & Materials
|
March 29, 2023
Ex vivo intervertebral disc cultures: degeneration-induction methods and their implications for clinical translation
E Salzer, T C Schmitz, V Hm Mouser, et al.
Vaccine
|
February 17, 2019
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents
Timo Vesikari, Lars Østergaard, Johannes Beeslaar, et al.
Vaccine
|
February 16, 2017
Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France
Muhamed-Kheir Taha, Julio Cesar Hawkins, Paul Liberator, et al.
Vaccine
|
July 13, 2004
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
Darron R Brown, Kenneth H Fife, Cosette M Wheeler, et al.
Journal of Molecular Biology
|
July 6, 2013
Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC
Alexey Gribenko, Lidia Mosyak, Sharmistha Ghosh, et al.
Page
of 26
Search research articles
Search
Showing results (151-160 of 254) with videos related to
Sort By:
Page
of 26
Clinical and Vaccine Immunology : CVI
|
August 17, 2012
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure
Julio Hawkins, Srinivas Kodali, Yury V Matsuka, et al.
The Lancet. Infectious Diseases
|
August 14, 2023
Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial
James Peterson, Daniel Drazan, Hanna Czajka, et al.
Open Forum Infectious Diseases
|
December 8, 2025
T-cell Response Induced by the BNT162b2 COVID-19 Vaccine in Children
Isabel Vogler, Stephanie Renken, Rolf Hilker, et al.
The Journal of Infection
|
October 5, 2019
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccine
Helen S Marshall, James Baber, Peter Richmond, et al.
Protein Expression and Purification
|
December 22, 1999
Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae
J C Cook, J G Joyce, H A George, et al.
European Cells & Materials
|
March 29, 2023
Ex vivo intervertebral disc cultures: degeneration-induction methods and their implications for clinical translation
E Salzer, T C Schmitz, V Hm Mouser, et al.
Vaccine
|
February 17, 2019
Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents
Timo Vesikari, Lars Østergaard, Johannes Beeslaar, et al.
Vaccine
|
February 16, 2017
Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France
Muhamed-Kheir Taha, Julio Cesar Hawkins, Paul Liberator, et al.
Vaccine
|
July 13, 2004
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
Darron R Brown, Kenneth H Fife, Cosette M Wheeler, et al.
Journal of Molecular Biology
|
July 6, 2013
Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC
Alexey Gribenko, Lidia Mosyak, Sharmistha Ghosh, et al.
Page
of 26